AVITA Medical
Stock Forecast, Prediction & Price Target
AVITA Medical Financial Estimates
AVITA Medical Revenue Estimates
AVITA Medical EBITDA Estimates
AVITA Medical Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 6/30/2018 | 6/30/2021 | 12/31/2022 | 12/31/2025 | 12/31/2026 | ||
Revenue
% change YoY
| $1.25M N/A | $14.26M 1036.33% | $50.56M 254.49% | Avg: $104.87M Low: $98.22M High: $109.12M avg. 107.42% | Avg: $134.08M Low: $125.57M High: $139.51M avg. 27.84% | ||
Net Income
% change YoY
| $-17.20M N/A | $-42.03M -144.27% | $-39.16M 6.80% | Avg: $-21.27M Low: $-88.92M High: $-11.21M avg. 45.69% | Avg: $-2.41M Low: $-62.23M High: $31.55M avg. 88.65% | ||
EBITDA
% change YoY
| $-18.55M N/A | $-41.52M -123.84% | $-39.56M 4.72% | Avg: $-100.31M Low: $-104.38M High: $-93.95M avg. -153.52% | Avg: $-128.25M Low: $-133.44M High: $-120.11M avg. -27.84% | ||
EPS
% change YoY
| -$1.84 N/A | -$2.07 -12.49% | -$1.57 24.15% | Avg: -$1.2 Low: -$3.56 High: -$0.45 avg. 23.81% | Avg: -$0.02 Low: -$2.49 High: $1.26 avg. 98.26% | ||
Operating Expenses
% change YoY
| $19.14M N/A | $53.96M 181.87% | $80.77M 49.67% | Avg: $773.42M Low: $724.35M High: $804.76M avg. 857.44% | Avg: $988.79M Low: $926.07M High: $1.02B avg. 27.84% | ||
FAQ
What is AVITA Medical stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 67.17% in 2025-2026.
We have gathered data from 5 analysts. Their low estimate is -88.92M, average is -21.27M and high is -11.21M.
What is AVITA Medical stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 67.63% in 2025-2026.
We have gathered data from 6 analysts. Their low revenue estimate is $98.22M, average is $104.87M and high is $109.12M.
What is AVITA Medical stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 61.04% in 2025-2026.
We have gathered data from 5 analysts. Their low earnings per share estimate is -$3.56, average is -$1.2 and high is $-0.44.
What is the best performing analyst?
In the last twelve months analysts have been covering AVITA Medical stock. The most successful analyst is Matt O'Brien.